Introduction
The Wnt secreted proteins of molecular weight ~40kd are a family of glycosylated-lipid-modified proteins which are powerful regulators of embryonic development, cell differentiation, and proliferation (Logan and Nusse, 2004, Sethi and Vidal-Puig, 2010) . Two distinct Wnt signaling pathways, the β-catenin-dependent canonical pathway and the β-catenin-independent so-called "noncanonical" pathway, including the Wnt/planar cell polarity pathway and the Wnt/Ca 2+ pathway, have been described. Two types of Wnt proteins have also been identified, one class of which comprises the canonical Wnts such as Wnt1 and Wnt3a. The other class is the "noncanonical" Wnts such as Wnt5a
and Wnt11 which act independently of or inhibit β-catenin signaling (Logan and Nusse, 2004) . According to the model of canonical Wnt action, in cells lacking a Wnt signal, glycogen synthase kinase (GSK) -3β phosphorylates β-catenin, inducing rapid degradation of β-catenin via the ubiquitin-proteasome pathway (MacDonald et al., 2009, Sethi and Vidal-Puig, 2010) . Canonical Wnt signaling causes stabilization of β-catenin which then translocates to the nucleus, where it interacts with the transcription factors that regulate expression of several target genes including c-myc and osteoprotegerin (OPG) (MacDonald et al., 2009 , Sato et al., 2009 ).
The Wnt signaling pathway has also been reported to be involved in regulation of bone formation (Krishnan et al., 2006 , Liu et al., 2008 , Tamura et al., 2010 . Loss of function of β-catenin in osteoblasts leads to low bone mass caused by increased numbers of osteoclasts resulting in increased bone resorption, indicating enhanced osteoclastogenesis from hematopoietic progenitor cells (Glass et al., 2005) . Previously, we have shown that canonical Wnt signaling induces OPG expression and analysis of the murine OPG gene promoter revealed that constitutively active forms of β-catenin regulate transcription of OPG via a promoter region containing two responsive sites (Sato et al., 2009 ). In addition, canonical Wnt signaling reduces receptor activator of NFkB ligand (RANKL) expression (Spencer et al., 2006 , Sato et al., 2009 ).
These observations suggest that canonical Wnt signaling regulates bone turnover via osteoclast formation from hematopoietic progenitor cells.
The Wnt signaling pathway plays a role in the regulation of hematopoiesis in bone marrow. Activation of canonical Wnt signaling enhances hematopoietic stem cell (HSC) self-renewal (Reya and Clevers, 2005, Staal and 6 Luis, 2010). In contrast, mice with conditional inactivation of β-catenin show normal hematopoietic cell development and repopulating activity of HSC (Cobas et al., 2004, Staal and Luis, 2010) . These controversial results indicate that the precise role of canonical Wnt signaling in bone marrow remains unclear.
Recently Kim et al. (2009) reported that the population of canonical Wnt receptor molecules and β-catenin accumulation were predominantly enriched in the stromal rather than the hematopoietic compartment of bone marrow (Kim et al., 2009 ). Therefore, we investigated the role of canonical Wnt function in bone marrow stromal cells.
Hematopoiesis and mobilization of mature blood cells into the bloodstream are dependent on various types of chemokines present in the bone marrow. Chemokines are small molecular weight molecules that function as chemoattractants and serve as regulators of blood cell maturation, trafficking and homing (Schall and Bacon, 1994, Howard et al., 1996) . CXCL12 (stromal derived factor: SDF-1α) and SDF-1β belong to the C-X-C chemokine family and were originally isolated from a murine bone marrow stromal cell line (Broxmeyer, 2008) . Both molecules are derived by alternative splicing of the CXCL12 gene and share similar biological activities. CXCL12 is widely produced by stromal and endothelial cells including bone marrow, skeletal muscle, liver, brain and heart, and CXCL12 binds predominantly to a G-protein coupled transmembrane glycoprotein cell surface chemokine receptor, CXCR4, widely expressed by several types of tissue-committed stem cells including HSC or hematopoietic progenitor cells (Ratajczak et al., 2006) . It has been reported that CXCL12-CXCR4 interactions mediate to maintain HSC niches on the endosteal surface of bone; the CXCL12-CXCR4 axis is involved in the homeostatic release of HSC from the bone marrow into the circulation, and also maintains the HSC pool in the bone marrow microenvironment, the so-called stem cell niche (Petit et al., 2002) . In vitro, a variety of cytokines and signaling molecules such as interleukin-1β, platelet-derived growth factor-BB, transforming growth factor (TGF) -β1 and tumor necrosis factor-α stimulate CXCL12 expression and protein secretion (Jung et al., 2006) . However, the regulation of CXCL12 production by Wnt signaling remains poorly understood.
In this report, we demonstrate that canonical Wnt signaling regulates CXCL12 production via the CXCL12 gene promoter in bone marrow stromal cells.
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Materials and Methods
Cell cultures
Cells of the mouse stromal cell line ST2 (RIKEN Cell Bank, Tsukuba, Japan)
were cultured in α-MEM containing 100 µg/ml of kanamycin (Meiji, Tokyo, Japan) and supplemented with 10% fetal bovine serum (FBS; SAFC Biosciences, Inc.
Lenexa, KS) at 37 o C in 100-mm cell culture dishes (Corning, Corning, NY) in a humidified atmosphere of 5% CO 2 in air. For osteoblastic differentiation of ST2 cells, the cells were cultured in α-MEM containing both 5 mM β-glycerophosphate and 100 µg/ml of ascorbic acid for 2 weeks. During culture, the medium was replaced every 3 days.
Bone marrow stromal cell (BMSC) cultures
Isolation of mouse bone marrow stromal cells (BMSCs) was as described previously (Matsumoto et al., 1995) . Briefly, marrow was flushed from the bones with Dulbecco's modified Eagle's medium containing 20% FBS, 100 µg/ml of kanamycin, and 10 -8 M dexamethasone (Sigma-Aldrich). After 7-10 days, the 9 cells reached confluence and were ready for use in experiments.
Expression plasmids
The plasmid constructs Wnt3a-pUSEamp and Wnt5a-pUSEamp were purchased from Upstate Biotechnology (Charlottesville, VA). The GSK-3β hairpin siRNA expression plasmid, pU6-GSK-3βHP1, was kindly provided by Dr.
D.L. Turner (Univ. Michigan, Ann Arbor, MI) (Yu et al., 2003a) . The sgRNA expression plasmids for silencing GSK-3β genes (pRNA Tin-H1.2/Neo-sgGSKL)
were constructed as described previously (Nakashima et al., 2007) . pU6pro (Yu et al., 2003a) or pRNATin-H1.2/Neo-Luc (Nakashima et al., 2007) was used as a non-targeting control. The plasmid DNA was transfected into cells using the cationic lipid reagent Lipofectamine PLUS (Invitrogen, Carlsbad, CA) as described previously (Nakashima et al., 2005) .
Generation of stable transfected cells and conditioned medium (CM)
ST2 cells were transfected with 1.0 µg of Wnt3a-pUSEamp or Wnt5a-pUSEamp 10 as described previously (Nakashima et al., 2005) . We denoted these cell lines Wnt3a-ST2 cells and Wnt5a-ST2 cells, respectively. The mouse Wnt3a-expressing cell line (L-Wnt3a cells) was cultured as described previously (Nemoto et al., 2009) . Conditioned medium (CM) was collected from each cell line and replaced with 8 ml fresh medium; cells were then cultured for a further 3 days.
Reverse transcription-polymerase chain reaction (RT-PCR)
PCR was used to analyze the transcript levels of CXCL12, RANKL, macrophage colony stimulating factor (M-CSF), alkaline phosphatase (ALP), Wnt3a and Wnt5a. Total RNA was extracted from the cells at the indicated time points using Isogen (Nippongene, Toyama, Japan) and treated with RNase-free DNase (Qiagen) to remove any contaminating genomic DNA. RT-PCR was performed as previously described (Nakashima et al., 2005) . The primer sequences for each gene were as follows: CXCL12, 5'-AGAGTCCGAGGAACGCTG C -3' (forward), 5'-CCCTGGCACTGAACTGGA-3' (reverse); RANKL, 5'-
To account for any difference in the amount of RNA, GAPDH was chosen as our endogenous control and amplified using the primers described above. The amplification products were electrophoresed on 2% agarose gels. Quantitative RT-PCR (qRT-PCR) was performed using assay-on-demand
TaqMan probes (Applied Biosystems, Foster city, CA) and StepOne ® real time PCR system. The relative level of gene expression was quantified using the comparative C T method with GAPDH as the endogenous control.
Quantification of CXCL12 by enzyme-linked immunosorbent assay (ELISA)
The level of CXCL12 protein was quantified using the mouse CXCL12
Immunoassay (Quantikine ® HS; R&D Systems, Minneapolis, MN).
Western blot analysis
Whole-cell extracts, dissolved in a buffer (50 mM Tris-HCl (pH 6.8), 2% SDS, 10% glycerol, 100 mM dithiothreitol), were separated by SDS/ 10% polyacrylamide gel electrophoresis, transferred to a nitrocellulose membrane and probed with anti-GSK-3β antibodies (BD biosciences, Palo Alto, CA) using the ECL Western Blotting Detection System (Amersham Biosciences, Piscataway, NJ).
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In vitro cell migration assay
Mouse bone marrow cells (1.5 x 10 5 in 100 µl) were loaded into Transwell chambers (5-µm pore filter Transwell, 24-well cell clusters; Corning, Corning, NY). Chambers were then placed into separate wells containing 600 µl of medium, either CM from ST2 cells, Wnt3a-ST2 cells or Wnt5a-ST2 cells, or control medium with or without 80 ng/ml of CXCL12 (R&D Systems). After overnight incubation at 37°C in 5% CO 2 in air, the upper chambers were removed and cells on the bottom surface of the filter were fixed with 100% methanol and stained with 1% toluidine blue. Cells were counted under a microscope at X40 magnification.
Osteoclast cultures
Murine bone marrow macrophages were obtained from the Primary Cell Co., Ltd.
(Sapporo, Japan). Cells (2 x 10 5 in 100 µl) were incubated in 48-well culture plates in 100 µl of DMEM with 50 ng/ml of M-CSF and 25 ng/ml of RANKL. In 14 order to investigate the effect on osteoclast formation, 50 or 100 µl of CM from Wnt3a-ST2 cells was added to the wells. The same amount of ST2 CM was added to separate wells as a control. After being cultured for 5 days, cells were fixed in 4% paraformaldehyde, and then tartrate-resistant acid phosphatase (TRAP; a marker enzyme of osteoclasts) activity was evaluated histochemically using the Sigma-Aldrich kit according to the manufacturer's instructions.
Numbers of TRAP-positive osteoclasts were counted. Each experiment was performed in triplicate.
Reporter constructs and assay for luciferase activity
Topflash is a Tcf reporter plasmid containing three copies of the Lef1/Tcf binding site (wild type) upstream of the thymidine kinase minimum promoter and luciferase open reading frame (Upstate Biotechnology, Lake Placid, NY).
Luciferase reporter plasmids for the CXCL12 promoter were generated as follows. The 1884-bp CXCL12 promoter fragment (-1834 to +50) was isolated from mouse genomic DNA by PCR and subcloned into the pGL4.12 vector (Promega) to generate the luciferase reporter plasmid (pCXCL12-1834Luc). The 15 deletion reporter constructs (pCXCL12-420Luc) (-420 to +50 CXCL12 promoter fragment) were made by PCR amplification. The nucleotide sequences of each promoter region were verified by sequencing. The reporter assay was performed as described previously (Nakashima et al., 2005) .
Reagents
Lithium chloride was purchased from Sigma-Aldrich.
Statistical analysis
All experiments were repeated three to four times and representative results are shown. The data are reported as the mean ± standard deviation, and were analyzed by Student's t-test, where values of p < 0.05 were considered significant.
Results
Wnt3a down-regulates CXCL12 expression in ST2 cells
To (Fig. 1B) . Using these cultures, we examined whether Wnt signaling specifically modulates CXCL12 gene expression. We found that CXCL12 mRNA was highly expressed in ST2 cells, whereas its expression level in Wnt3a-ST2 cells was reduced (Fig.1A ).
ST2 cells express at least two cytokines essential for osteoclast differentiation:
RANKL and M-CSF. RANKL expression was suppressed in Wnt3a-transfected cells ( Fig. 1A and 1E ), whereas expression of M-CSF was not changed after stable transfection with either Wnt3a or Wnt5a (Fig. 1A) .
The expression level of CXCL12 was also determined by real time quantitative reverse transcription-polymerase chain reaction (qRT-PCR) assay.
The level of CXCL12 mRNA was reduced by 76% in response to Wnt3a transfection (Wnt3a-ST2 cells) compared to untransfected ST2 cells (Fig. 1C left). The amount of CXCL12 protein released from Wnt3a-ST2 cells also decreased by 47% compared with control ST2 cells (Fig. 1D ), indicating that Wnt3a specifically down-regulates CXCL12 expression in ST2 cells. To confirm that regulation by Wnt3a also occurs in BMSC, we examined CXCL12 expression in mouse BMSC following addition of Wnt3a-CM, using qRT-PCR. As shown in Fig. 1C right, while control-CM did not reduce CXCL12 expression, the
To investigate whether regulation of CXCL12 expression depends upon differentiation stage, ST2 cells were cultured in α-MEM containing ascorbic acid and β-glycerophosphate for 2 weeks. These cells have been shown to exhibit characteristics typical of osteoblasts, with induction of expression of mRNAs for marker proteins of osteoblastic differentiation and formation of mineralized nodules (Otsuka et al., 1999) . In these cultures, following addition of Wnt3a-CM or control-CM, then culture for 24 h, CXCX12 expression was determined using qRT-PCR. As shown in Fig. 1F , CXCL12 expression in differentiated ST2 cells (2 weeks) was lower (~21%) than in undifferentiated ST2 cells (1 day). While control-CM did not reduce CXCL12 expression, the addition of 20% (v/v) of Wnt3a-CM also did not regulate CXCL12 expression in differentiated ST2 cells (Fig. 1F ).
LiCl down-regulates CXCL12 expression in ST2 cells
Since LiCl is known to enhance canonical Wnt signaling, we analyzed the effects on CXCL12 expression of culturing cells with LiCl. When we analyzed the time course of CXCL12 mRNA expression in ST2 cells, we found that the level of CXCL12 mRNA began to decrease after 3 h and a time-dependent decrease in CXCL12 mRNA levels was observed up to 48 h ( Fig. 2A) . The level of CXCL12 mRNA decreased significantly after addition of 2 mM LiCl and further decreased 19 with doses up to 20 mM (Fig. 2B) . The level of CXCL12 protein in ST2 cells declined to 25% or 17% upon treatment with 10 or 20 mM LiCl, respectively, for 24 h (Fig. 2C) .
Knock-down of GSK-3β Decreases CXCL12 Production
Since GSK-3β is known to mediate canonical Wnt signaling, we examined the effect of knockdown of GSK-3β using either RNA interference or tRNase Z L -utilizing efficacious gene silencing (TRUE gene silencing) (Tamura et al., 2003 , Nakashima et al., 2007 , Elbarbary et al., 2009 ) upon CXCL12 induction.
Knock-down of GSK-3β was confirmed by Western blot analysis. We found that the level of GSK-3β protein decreased to approximately 10% (GSK-3βHP1, lane 2) or 23% (sgGSKL, lane 3) of the nontargeted control level (lane 1), confirming that both the siRNA and the sgRNA were effective in silencing the endogenous GSK-3β gene (Fig. 2D ). Since suppression of the GSK-3β protein might lead to down-regulation of canonical Wnt signaling, levels of CXCL12 expression were examined. Both CXCL12 mRNA expression and CXCL12 protein in the culture supernatant of ST2 cells significantly decreased after transfection with 20 GSK-3βHP1 or sgGSKL ( Fig. 2E and 2F ). These results indicate that CXCL12 induction is GSK-3β dependent, and that the canonical Wnt signaling pathway may be involved in regulating CXCL12 induction.
Repression of the migration of bone marrow cells by Wnt3a in ST2 cells
To evaluate the potential biological relevance of the regulation of CXCL12 by canonical Wnt signaling, we examined whether it has any effect on the directed (pCXCL12-420luc) was also suppressed by LiCl treatment (Fig. 5 ). This analysis implies the presence of transcriptional machinery that is sensitive to interference by canonical Wnt signaling and that regulates transcriptional activity through interaction with the CXCL12 gene promoter downstream from nucleotide position -420.
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Discussion
In bone marrow, CXCL12 appears to be constitutively expressed by stromal and endothelial cells. In the present study, we used the stromal cell line ST2, derived from mouse bone marrow, to examine CXCL12 expression. In normal culture, ST2 cells have the characteristics of preadipocytes and none of the features typical of the osteoblastic phenotype (Yamaguchi et al., 1996) .
However ST2 cells cultured with ascorbic acid exhibited characteristics typical of osteoblasts with the formation of mineralized nodules, indicating that ST2 cells are pre-osteoblastic stromal cells (Otsuka et al., 1999 (Calvi et al., 2003 , Zhang et al., 2003 , Arai et al., 2004 . CXCL12 is a powerful chemoattractant for mature and early hematopoietic cells that express the CD34 antigen (Lataillade et al., 2000) . Canonical Wnts are present in the bone marrow microenvironment and constitute a pivotal group of molecules controlling HSC cell proliferation and differentiation. Recently, Kim et al. reported activation of canonical Wnt signaling in the endosteal stroma of bone marrow by systemic injection of Wnt3a (Kim et al., 2009 , Oh, 2010 . Down-regulation of CXCL12 by canonical Wnt signaling in stroma may therefore play a role in regulating HSC and progenitor mobilization.
Proteolytic degradation of CXCL12 in the bone marrow has also been shown to play a role in regulating HSC and progenitor mobilization into the peripheral circulation (Lévesque et al., 2003) . However, the mechanism underlying this effect is not yet known.
Regulation of CXCL12 production by various growth factors and 25 inflammatory cytokines has been reported. Wright et al. (Hatakeyama et al., 2003) reported that TGF-β1 down-regulates CXCL12 expression in the stromal cell line MS-5. Similar to our studies, this decrease in CXCL12 production by MS-5 cells correlated with decreased CXCL12-dependent migratory activity (Hatakeyama et al., 2003) . They indicate that "primitive" mesenchymal This differentiation and maturation is mediated by RANKL, which is expressed on osteoblasts, and by receptor activator of NFkB (RANK), a cognate receptor expressed on osteoclast precursor cells (Theoleyre et al., 2004) . We have previously shown that canonical Wnt signaling regulates expression of OPG and RANKL, a finding which supports a role for osteoblastic canonical Wnt signaling in the down-regulation of osteoclast differentiation and formation via regulation of OPG and RANKL (Sato et al., 2009 , Tamura et al., 2010 . During osteoclastogenesis, CXCL12 has been reported to recruit osteoclast precursors by inducing chemotaxis and collagen transmigration (Yu et al., 2003b, Gronthos 28 and Zannettino, 2007) . This may serve as a mechanism to localize osteoclast precursors to the bone surface for subsequent activation into resorptive osteoclasts, indicating that CXCL12 is a crucial osteoclastogenesis factor that enhances the formation and activity of osteoclasts and increases bone resorption in vivo. Our studies suggest that canonical Wnt signaling may act indirectly on the down-regulation of osteoclast differentiation and formation, not only by regulating OPG and RANKL but also by regulation of CXCL12 in the bone marrow.
In conclusion, we have shown that canonical Wnt signaling regulates CXCL12 gene expression, and this is the first study linking chemokine expression to Wnt signaling in bone marrow. As such, these investigations may provide important new information pertaining to the molecular basis of the regulation of HSC or osteoclast precursors in the bone marrow microenvironment. 
